Diabetes Care:肾功能受损或与导致视网膜血流降低

2013-05-06 医学论坛报 医学论坛报

日本学者的一项研究表明,肾功能受损可能与视网膜血流(RBF)降低具有相关性。论文于2012年11月30日在线发表于《糖尿病护理》(Diabetes Care)杂志。 此项研究共纳入169例(169只眼)平均年龄为59岁的2型糖尿病患者;受试者无或伴轻微糖尿病视网膜病变,并且无或伴微量蛋白尿。通过同时测定视网膜血管直径和血流速度获取RBF。利用通过年龄和血清肌酐计算的估计肾小球滤过率评估肾功能。

日本学者的一项研究表明,肾功能受损可能与视网膜血流(RBF)降低具有相关性。论文于2012年11月30日在线发表于《糖尿病护理》(Diabetes Care)杂志。

此项研究共纳入169例(169只眼)平均年龄为59岁的2型糖尿病患者;受试者无或伴轻微糖尿病视网膜病变,并且无或伴微量蛋白尿。通过同时测定视网膜血管直径和血流速度获取RBF。利用通过年龄和血清肌酐计算的估计肾小球滤过率评估肾功能。

结果显示,无慢性肾病(CKD)以及1、2和3期CKD患者分别为99、22、27和21例。与无CKD患者相比,3期CKD患者的RBF随血管直径减小而显着降低,但血流速度与之无相关性。多重回归分析显示,CKD分期与RBF降低呈显着独立相关(P=0.02)。

肾功能相关的拓展阅读:


Relationship between retinal blood flow and renal function in patients with type 2 diabetes and chronic kidney disease.
OBJECTIVE
To study the relationship between retinal microcirculation and renal function in patients with type 2 diabetes.
RESEARCH DESIGN AND METHODS
Using a laser Doppler velocimetry system, we obtained the retinal blood flow (RBF) values by simultaneously measuring the retinal vessel diameter and blood velocity. To determine if the RBF is affected in the presence of renal dysfunction, we also evaluated the renal function using the estimated glomerular filtration rate calculated by age and serum creatinine level.
RESULTS
We recruited 169 eyes of 169 consecutive Japanese patients with type 2 diabetes, no or minimal diabetic retinopathy, and normo/microalbuminuria (mean age ± SD, 59.0 ± 11.1 years). We divided the patients into four groups based on the stage of chronic kidney disease (CKD) (non-CKD, n = 99; CKD stage 1, n = 22; stage 2, n = 27; stage 3, n = 21). We found significant (P = 0.035) decreases in RBF with decreased vessel diameter (P = 0.017) but no difference in blood velocity (P = 0.54) in stage 3 CKD compared with the non-CKD group. Multiple regression analysis showed that the CKD stage was significantly (P = 0.02) and independently associated with decreased RBF.
CONCLUSIONS
Our results indicated that the vessel diameter and RBF in the retinal arterioles decrease in patients with type 2 diabetes with stage 3 CKD, suggesting that impaired renal function might be associated with decreased RBF, probably via constriction of the retinal arterioles, in early-phase diabetic retinopathy.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1850531, encodeId=0f921850531e1, content=<a href='/topic/show?id=46c682469e4' target=_blank style='color:#2F92EE;'>#肾功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82469, encryptionId=46c682469e4, topicName=肾功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28d456, createdName=yese, createdTime=Wed Dec 25 15:56:00 CST 2013, time=2013-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636666, encodeId=3009163666636, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Oct 24 00:56:00 CST 2013, time=2013-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759280, encodeId=01601e592801d, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Tue Jul 23 18:56:00 CST 2013, time=2013-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901085, encodeId=cc9e19010858b, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Jun 13 19:56:00 CST 2013, time=2013-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269781, encodeId=12101269e8196, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Wed May 08 14:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]
    2013-12-25 yese
  2. [GetPortalCommentsPageByObjectIdResponse(id=1850531, encodeId=0f921850531e1, content=<a href='/topic/show?id=46c682469e4' target=_blank style='color:#2F92EE;'>#肾功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82469, encryptionId=46c682469e4, topicName=肾功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28d456, createdName=yese, createdTime=Wed Dec 25 15:56:00 CST 2013, time=2013-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636666, encodeId=3009163666636, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Oct 24 00:56:00 CST 2013, time=2013-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759280, encodeId=01601e592801d, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Tue Jul 23 18:56:00 CST 2013, time=2013-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901085, encodeId=cc9e19010858b, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Jun 13 19:56:00 CST 2013, time=2013-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269781, encodeId=12101269e8196, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Wed May 08 14:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1850531, encodeId=0f921850531e1, content=<a href='/topic/show?id=46c682469e4' target=_blank style='color:#2F92EE;'>#肾功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82469, encryptionId=46c682469e4, topicName=肾功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28d456, createdName=yese, createdTime=Wed Dec 25 15:56:00 CST 2013, time=2013-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636666, encodeId=3009163666636, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Oct 24 00:56:00 CST 2013, time=2013-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759280, encodeId=01601e592801d, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Tue Jul 23 18:56:00 CST 2013, time=2013-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901085, encodeId=cc9e19010858b, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Jun 13 19:56:00 CST 2013, time=2013-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269781, encodeId=12101269e8196, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Wed May 08 14:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1850531, encodeId=0f921850531e1, content=<a href='/topic/show?id=46c682469e4' target=_blank style='color:#2F92EE;'>#肾功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82469, encryptionId=46c682469e4, topicName=肾功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28d456, createdName=yese, createdTime=Wed Dec 25 15:56:00 CST 2013, time=2013-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636666, encodeId=3009163666636, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Oct 24 00:56:00 CST 2013, time=2013-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759280, encodeId=01601e592801d, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Tue Jul 23 18:56:00 CST 2013, time=2013-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901085, encodeId=cc9e19010858b, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Jun 13 19:56:00 CST 2013, time=2013-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269781, encodeId=12101269e8196, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Wed May 08 14:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1850531, encodeId=0f921850531e1, content=<a href='/topic/show?id=46c682469e4' target=_blank style='color:#2F92EE;'>#肾功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82469, encryptionId=46c682469e4, topicName=肾功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28d456, createdName=yese, createdTime=Wed Dec 25 15:56:00 CST 2013, time=2013-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636666, encodeId=3009163666636, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Oct 24 00:56:00 CST 2013, time=2013-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759280, encodeId=01601e592801d, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Tue Jul 23 18:56:00 CST 2013, time=2013-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901085, encodeId=cc9e19010858b, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Jun 13 19:56:00 CST 2013, time=2013-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269781, encodeId=12101269e8196, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Wed May 08 14:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]

相关资讯

Stroke:DWI-ASPECTS能够预测大脑中动脉梗塞患者tPA溶栓后早期效果

弥散加权成像和Alberta卒中计划早期CT评分(DWI-ASPECTS)是评价梗塞范围和严重程度的重要评分标准。对于大脑中动脉主干梗塞的患者,可能可以预测静脉用重组组织纤溶酶原激活剂(静脉溶栓)后短期神经功能恢复情况。为此,日本川崎医学院神经科的Junya Aoki博士等人进行了一项研究,研究结果在线发表在2012年12月4日的Stroke杂志上。研究结果发现:DWI-ASPECTS能够预测大脑

Sleep:揭示调节食欲的激素的作用方式因性别而异

刊登在国际杂志Sleep上的一篇研究报告指出,增加成人的睡眠量可以导致其食物摄取量降低,而且在男性和女性中和食物摄取相关的激素分泌过程也表现出不同。研究者Marie-Pierre St-Onge博士说,在健康正常体重的参与者中,通过限制其睡眠就会限制其代谢风险因子的效应,而且会通过在男、女机体中不同的调节荷尔蒙分泌的方式来影响其食物的摄取量。 研究者针对睡眠对葡萄糖、胰岛素以及瘦素的影响,以及饥

Sci Transl Med:开发出用于研究人类疾病的肺部微芯片装置

2012年11月9日 --刊登在11月7日的国际杂志Science Translation Medicine上的一篇研究报告中,来自哈佛大学的研究者使用活的人体细胞在微芯片中模仿肺部水肿,研究者使用这种肺部芯片模型(lung-on-a-chip)来研究药物的毒性以及开发出新型的疾病疗法。 研究者Donald说,很多制药公司在细胞培养和动物试验上花费了大量时间和金钱,只为开发出新型的疾病疗法或者新

PLoS Pathog:新研究揭示沙门氏菌如何在体内散播

2012年12月6日讯 /生物谷BIOON/ --英国剑桥大学科学家12月6日发表在PLoS Pathogens杂志上的一项研究揭示了细菌在体内扩散的新机制,可能确定了能防止细胞传播感染的靶标。 沙门氏菌是一大威胁公众健康,引起全身性疾病(伤寒和副伤寒),肠胃炎和非伤寒败血症(NTS)的病毒。在自然感染过程中,沙门氏菌通常是通过污染水或食物感染人类,健康人群通过与病毒携带体接触也会感染。目前,沙

Nature:炎症性肠道疾病(IBD)的遗传研究

2012年11月6日--最近,一个国际科学家小组研究发现了炎症性肠道疾病(IBD)的遗传基础。克罗恩氏病和溃疡性结肠炎是炎症性肠道疾病最常见的两种形式。 蒙特利尔心脏研究所与蒙特利尔大学医学副教授John Rioux博士已经确定了71个基因区域与炎性肠道疾病(IBD)发病有关,迄今发现与IBD发病相关的基因总数增加至163个。此外,该研究指出,这些基因区域表现出显著的重叠功效即也与自身免

Sci Transl Med:MECP2复制影响免疫系统以及大脑发育

1999年,Huda Zoghbi博士和他的同事在贝勒医学院确定了Rett综合征(一种在出生后开始的神经系统疾病,)的遗传原因即MECP2基因突变。MeCP2蛋白质与基因太少造成女孩逐渐失去讲话等许多认知功能。 2005年,其他研究人员发现硬币的另一面--MECP2复制综合症。这一关键蛋白质太多会导致其他神经系统的问题,主要发生在男性婴儿上,能影响他们的认知和神经系统的发育。然而,这些男孩有另一